U.S. market Closed. Opens in 5 hours

NARI | Inari Medical, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue493.63M383.47M276.98M139.67M51.13M6.83M
Cost of Revenue64.87M44.51M24.76M13.11M5.91M1.28M
Gross Profit428.76M338.96M252.23M126.56M45.22M5.55M
Operating Expenses432.40M367.06M241.38M108.14M44.42M14.69M
Selling, General & Admin344.86M292.84M190.37M89.75M37.20M10.70M
Research & Development87.53M74.22M51.02M18.40M7.22M3.99M
Other Operating Expenses2.86M356.00K-18.00K-662.00K-205.17K-133.00K
Operating Income-3.63M-28.10M6.67M18.42M801.49K-9.14M
Other Expenses / Income7.88M1.91M4.01M-4.63M-1.99M-218.00K
Before Tax Income4.25M-26.18M10.69M13.79M-1.19M-10.15M
Income Tax Expenses5.88M3.08M845.00K-912.00K715.29K-126.00K
Net Income-1.64M-29.27M9.84M13.79M-1.91M-10.15M
Interest Expenses196.00K294.00K295.00K1.14M920.46K887.00K
Basic Shares Outstanding56.77M52.84M49.82M32.03M48.18M38.37M
Diluted Shares Outstanding56.77M52.84M55.59M51.55M48.18M44.95M
EBITDA7.11M-18.77M10.98M18.24M1.30M-8.90M
EBITDA Margin1.44%-4.90%3.96%13.06%2.54%-130.30%
EBIT4.44M-25.89M10.98M14.01M-271.37K-9.39M
EBIT Margin0.90%-6.75%3.96%10.03%-0.53%-137.53%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙